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The burden of disease associated with being African-American in the US, and the contribution of socio-economic status
(SES) to that burden have not been quantified. We derived burden of disease estimates for African-Americans and whites by
age group, with and without adjustment for SES (income and education). We used (1) EQ-5D Index scores from the 2000 US
Medical Expenditure Panel Survey to derive quality-adjusted life year (QALY) compatible estimates of health-related quality
of life (HRQL); (2) 1990–1992 US National Health Interview Survey data linked to National Death Index data through 1995
to derive mortality risks; and (3) 2000 US mortality data from the National Center for Health Statistics to derive current
mortality estimates for the US population. We found that relative to whites, African-Americans suffer 67,000 more deaths
annually, resulting in 2.2 million years of life lost, and 1.1 million years after SES adjustment. Total QALYs lost (HRQL and
mortality) dropped from 2.3 million to 902,000 after SES adjustment. SES differences between African-Americans and whites
appear to explain all the HRQL disparity but only half the mortality disparity. Better understanding of the disparate effects
of SES may inform interventions to address health disparities adversely affecting African-Americans.
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haomia@yahoo.com (H. Jia).whites, with most studies showing a 30% higher
age-adjusted risk of mortality (Arias, Anderson,
Kung, Murphy, & Kochanek, 2003). Socio-econom-
ic status (SES) accounts for much of this difference,
but differences in mortality persist after adjustment
(Kawachi, Daniels, & Robinson, 2005; Williams,
1999). A higher prevalence of hypertension, HIV,
ischemic heart disease, stroke, and cancer appears
to be driving higher rates of mortality in this group.
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1992; Wong, Shapiro, Boscardin, & Ettner, 2002).
To our knowledge, the burden of disease among
African-Americans in the US has not been reported.
Burden of disease analyses provide useful informa-
tion on overall societal impact of illness, ideally
combining information on both morbidity and
mortality (Field & Gold, 1998; Michaud, Murray,
& Bloom, 2001). Recently, it has become possible to
quantify the overall annual and lifetime morbidity
and mortality in a single measure, the quality-
adjusted life year (QALY).
The QALY is based on a subjective quantification
of illness called health-related quality of life
(HRQL). The advantages of using HRQL scores
are that: (1) they can be used to adjust years of life
lived and lost, thereby producing a summary
measure that captures both morbidity and mortality
in a single number; (2) they capture the cumulative
effects of multiple conditions; and (3) they capture
both psychological and physiological dimensions of
illness. Because they are based on perceptions and
include psychological dimensions of illness, how-
ever, two individuals with the same biomedical
disease of the same severity can report different
scores. Further, HRQL scores cannot capture
morbidity not affecting health perceptions.
Quantification of the burden of disease due to
race and the influence of SES on this burden may
assist policymakers in prioritizing social interven-
tions (Field & Gold, 1998). In this study, we
examine the burden of disease borne by African-
Americans relative to whites before and after
adjusting for income and education. We use
comprehensive outcome measures, including annual
years of life lost (YLL) and years lost to HRQL
impairments. We also examine the losses among
individuals over a lifetime. Finally, we examine




In this study, we examine life expectancy and
quality-adjusted life expectancy (QALE) among
adult African-Americans relative to whites, exclud-
ing Hispanics, before and after adjusting for SES.
We also examine annual losses, including the
number of deaths, the YLL, and QALYs lost to
HRQL impairments alone.A QALY is a summary measure of population
health that includes both morbidity and mortality.
One QALY is equal to 1 year of life lived in perfect
health, and QALE is the life expectancy in perfect
health. The calculation of QALE is achieved using
HRQL scores, which provide an assessment of the
perceived importance people place on the morbidity
associated with illness. These scores assume a value
anchored at 1 (perfect health) and 0 (death). A
simplified estimation of QALE is the product of life
expectancy and the average HRQL score.
Datasets
We obtained HRQL values from the 2000
Medical Expenditure Panel Survey (MEPS, accessed
03/14/2005, http://www.meps.ahrq.gov/), and mor-
tality ratios from the 1990–1992 National Health
Interview Surveys (NHIS, accessed 03/14/2005,
http://www.cdc.gov/nchs/nhis.htm) linked to the
National Death Index through the end of 1995
(NDI, accessed 03/14/2005, http://www.cdc.gov/
nchs/r&d/nchs_datalinkage/nhis_data_linkage_acti-
vities.htm). The MEPS sample is a subset of the
NHIS survey, so these surveys provide comparable
nationally representative data of the non-institutio-
nalized civilian population of the United States.
Respondents in the surveys self-define their race.
The MEPS, conducted by the Agency for Health
Research and Quality, includes detailed socio-
demographic, health care utilization, and health
status information. The household income data
were recoded into discrete categories relating house-
hold income to the federal poverty level (o100%,
100–124%, 125–199%, 200–399%, and X400%).
Individual educational attainment data were re-
coded into four discrete categories (o12 years, 12
years, 13–15 years, and X16 years).
In 2000, the MEPS included, for persons over age
18, five questions that can be used to generate the
EuroQol EQ-5D Index (Cohen, 2003), a QALY
compatible and preference-based instrument (Rabin
& de Charro, 2001). The EQ-5D Index assesses: (1)
mobility, (2) self-care, (3) ability to perform usual
activities, (4) pain or discomfort, and (5) anxiety or
depression. Each dimension is scaled as ‘‘no
problem,’’ ‘‘some problem,’’ or ‘‘extreme problem.’’
EQ-5D Index scores were obtained from a repre-
sentative sub-sample of 14,382 African-American
and white adults. Responses to the five EQ-5D
questions were transformed into preference
weighted HRQL scores, using recently published
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The NHIS contains similar socio-demographic
variables to those in the MEPS and can be linked to
NDI data, allowing for mortality analyses of
subjects in the original sample. The 1990–1992
NHIS linked data sampled 256,900 adults, 11,214 of
whom died by the end of 1995.
Calculations
Analyses were conducted using STATA (version
8.2, StataCorp, College Station, TX) and SUDAAN
(version 8.0.1, Research Triangle Institute, Research
Triangle Park, NC) statistical packages that allow
adjustment for the complex sampling design used in
the MEPS and NHIS.
Linear regressions were used to derive age-group
specific EQ-5D Index scores for persons 18 and
older. Cox proportional hazard survival models
were used to generate the hazard ratios (HRs).
Analyses compared African-Americans relative to
white subjects with and without adjusting for SES
(income and education categories). Age groups used
the following age intervals: o25, 25–44, 45–64,
65–74, and 75+. Each analysis also adjusted for age
and age squared.
Abridged life tables were generated for African-
Americans and whites for the year 2000 using age
intervals of 5 years (or less) to age 90 and over.
These tables were populated using mortality data
obtained from the National Center for Health
Statistics (Anderson, 2000; Minino, Arias, Kocha-
nek, Murphy, & Smith, 2002). Life tables are
constructed using a hypothetical cohort of 100,000
individuals exposed to a risk of death over each age
interval. For instance, if the risk of death between
age 0 and 1 is 0.00693, then 0.00693 100,000 ¼
693 persons will die over this interval, leaving
100,000–693 ¼ 99,307 persons to be exposed to the
risk of death for persons aged 1–4. To calculate life
expectancy at birth, the number of person years in
each age interval are summed and divided by the
number of persons at the start of the first interval
(100,000).
These tables used 2000 mortality data and
calculated life expectancy for that year. The age
group HRs generated from NHIS data were then
multiplied by the mortality rates in the life tables to
obtain rates adjusted for SES. This was done to
estimate life expectancy for persons in each self-
identified race group.This technique assumes that HRs of mortality
between the race groups under study, and the
relative effects of education and income, have not
changed between the 1990–1995 NHIS sample
follow-up and the year 2000. To calculate QALE,
the number of person years in each interval is
multiplied by the mean HRQL score for that
interval. These health-adjusted person years are
again summed over all age intervals and divided by
the persons at the start of the first interval. Further
details pertaining to the general construction of our
life tables have been published elsewhere (Anderson,
2000; Muennig, 2002).




where M is the total number of deaths in age
interval x, e the proportion of M excess deaths in
age interval x, and p the proportion of African-
Americans in age interval x. Total deaths were
obtained from death certificate data (Minino et al.,
2002). In 2000, there were 1,301,202 deaths among
African-American and white adults.




where x is the age interval (o25, 25–44, 45–64,
65–74, and 75+), Dx is the number of race-related
deaths within age interval x and Lx is the life
expectancy for white persons at the mid-point of age
interval x. Lx was obtained from life table values for
the reference group (whites) to reflect the full
potential life lost.




where HAx is the HRQL score for whites in age
interval x, HBx is the HRQL score for African-
Americans, and Px is the African-American popula-
tion in age interval x. Differences were also
calculated for the African-American population
and white population adjusted for SES.
Total QALYs (due to both morbidity and






Basic demographic characteristics of the African-American (AA)
and white populations (White) relative to the average person
(Total) in the 2000 Medical Expenditure Panel Survey
Total AA White
Age
18–44 51.7 58.4 48.2
45–64 31.4 29.4 32.8
65+ 16.9 12.2 19.0
Sex
Male 47.7 43.5 47.9
Female 52.2 56.4 52.1
Marital status
Married 57.4 37.3 60.4
Widowed 7.2 7.2 7.7
Divorced 11.7 13.6 11.9
Separated 1.7 3.8 1.2
Never married 22.0 38.1 18.8
Metropolitan statistical area (MSA)
Non-MSA 19.7 13.2 22.8
MSA 80.5 86.8 77.2
Insurance
Any private 74.9 64.6 79.7
Public only 13.3 19.1 12.1
Uninsured 11.8 16.2 8.2
Self-reported health
Fair or poor 14.7 15.9 13.8
Self-reported conditions
Diabetes 6.5 9.2 5.9
Asthma 9.2 9.9 9.5
Hypertension 20.4 24.6 21.2
Heart disease 10.3 8.6 11.4
Number of conditions
0 66.7 64.0 65.4
1 22.9 23.5 23.9
2+ 10.5 12.5 10.7
P. Franks et al. / Social Science & Medicine 62 (2006) 2469–24782472where QMx is the total number of QALYs due to
morbidity in age interval x, Hx is the HRQL score
for persons in the BMI category of interest in age
interval x, and Yx is the number of YLL in age
interval x.
Gender differences
Limited sample size precluded producing burden
of disease estimates by age and gender. However, it
was possible to age-adjust HRs and then apply the
formula for race-related deaths for all age groups
together in a secondary analysis. While this method
is known to overestimate total deaths when hazards
decline with age, it will produce proportionate
breakdown in deaths by gender as long as hazards
decline similarly for males and females (Flegal,
Graubard, & Williamson, 2004). Likewise, we
estimated total QALYs lost to morbidity by gender
using an age-adjusted analysis.
Results
Table 1 shows the demographic profile of the
MEPS sample for the US overall, for African-
Americans, and whites. African-Americans were
more likely to be younger, female, unmarried, live in
a metropolitan statistical area, be uninsured, have
worse self-rated health, and have two or more
conditions than whites. While African-Americans
are about 40% less likely to be married than whites,
the likelihood of being a widow is roughly the same
for both groups. In this sample, the African-
American group was also more likely to report
having diabetes and hypertension, but not asthma
or heart disease.
Table 2 shows HRQL scores and HRs for all
groups under study. The gap in HRQL due to
morbidity between African-Americans and whites is
small with or without SES adjustment. Conversely,
the HRs show a marked racial disparity, particu-
larly for younger persons, an effect that is notice-
ably attenuated by SES adjustment.
Table 3 shows the annual burden of disease
among African-Americans relative to whites before
and after adjusting for SES. African-Americans
experience about 67,000 more deaths than they
would have had their mortality rates been similar to
whites. This translates into 2.2 million more YLL.
After adjusting for SES, these numbers drop to
about 38,000 lives and 1.1 million YLL. Thus,
roughly 29,000 of the lives lost and 1.1 million yearslost annually may be attributable to differences in
income and education between the groups.
Racial differences between adjusted and unad-
justed values in the QALY analysis produced
paradoxical results. African-Americans lost about
435,000 QALYs to HRQL impairments in 2000
relative to whites. However, after adjusting for SES,
African-Americans experience a gain of 45,000
QALYs relative to whites. Total QALYs lost
(HRQL impairments and mortality combined) drop
from 2.3 million to 902,000.
Table 4 shows life expectancy and QALE before
and after SES adjustment for African-Americans
and whites. (Note that these represent changes in
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Health-related quality of life (HRQL) and mortality hazard




18–25 0.93 0.93 0.92
25–44 0.88 0.89 0.89
45–64 0.81 0.85 0.85
65–74 0.79 0.82 0.81
475 0.71 0.74 0.75







Race-associated burden of disease before and after controlling































Notes: QALYs are quality-adjusted health years. HRQL is
health-related quality of life. Total is combined HRQL impair-
ments and mortality effects. Numbers rounded to nearest
thousand.
Table 4
Life expectancy and health-adjusted life expectancy by race and
socio-economic status (SES), 2000
African-Americans Whites
Unadjusted SES adjusted Reference
Life expectancy, birth 71.4 74.1 77.2
Life expectancy, at age 18 55.2 57.5 59.9
QALEa, at age 18 46.0 48.0 49.2
aQuality-adjusted life expectancy.
P. Franks et al. / Social Science & Medicine 62 (2006) 2469–2478 2473QALYs over an individual’s lifetime rather than
total annual changes.) Life expectancy at birth for
African-Americans was 71.4 years in 2000 and 77.2
years for their white counterparts. After adjusting
for SES, the difference in life expectancy at birth
drops from approximately 6 years to about 3 years.
QALE differences at age 18 drop from approxi-
mately 3 years to about 1 year.
Gender differences
Using age-adjusted analyses by gender we ob-
served similar risks for African-Americans of both
genders (relative to whites of both genders); for men
the adjusted HR ¼ 1.48 (95% confidence interval
[CI] ¼ 1.36, 1.61) and for women the adjusted
HR ¼ 1.46(95% CI ¼ 1.35, 1.59). After adjusting
for SES, the male HR ¼ 1.23 (95% CI ¼ 1.12, 1.39)
and the female HR ¼ 1.32 (95% CI ¼ 1.22, 1.44).
Although these figures suggest a more profound
effect of SES on African-American men, the wide
overlap of the confidence intervals suggests these
differences are not statistically significant. Further,
analyses including an interaction term between
gender and race revealed that the interaction was
not statistically significant without (p40:8) or with
(p40:7) SES adjustment.
An analysis of the age-adjusted relationship
between race and EQ-5D scores using ordinary
least-squares regression revealed that African-
Americans had lower HRQL scores than whites
(0.015, 95% CI ¼ 0.027, 0.004), an effect thatwas statistically significant in women (0.019, 95%
CI ¼ 0.034, 0.005), but not men (0.009, 95%
CI ¼ 0.026, 0.008). However, the interaction
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SES adjustment the racial disparity became non-
significant overall (0.005, 95% CI ¼ 0.007, 0.017)
and by gender.
Discussion
Relative to whites, African-Americans suffer
67,000 more deaths annually, resulting in 2.2 million
YLL. YLL drop to 1.1 million after adjustment for
SES. Total QALYs fall more dramatically with SES
adjustment, dropping from 2.3 million to 902,000.
This larger drop is attributable to the apparent
obliteration of race disparities in HRQL after SES
adjustment. The disparate effects of SES on
mortality and morbidity differences in African-
Americans and whites have also been noted
previously. Analyzing the 1987 National Medical
Expenditure Survey together with 5-year mortality
follow-up data, Franks et al. found that SES
explained the racial disparity in morbidity (using a
non-QALY compatible measure similar to the SF-
20) but less of the disparity in mortality (Franks,
Gold, & Fiscella, 2003).
In contrast to the profound racial differences in
mortality, the racial differences in HRQL are quite
small, with or without adjustment for SES. We
observed an age-adjusted difference in EQ-5D
scores of 0.015, which became non-significant after
SES adjustment. What constitutes a minimally
clinically significant difference in preference scores
is debatable (Kathleen et al., 2005; Walters &
Brazier, 2005); however, this difference is well below
the threshold of 0.03 suggested for several pre-
ference-based HRQL measures (Dolan, 1997; Groo-
tendorst, Feeny, & Furlong, 2000; Walters &
Brazier, 2003).
There are several possible explanations for the
apparently different contributions SES makes to
HRQL and mortality disparities. As noted in the
introduction, HRQL measures, while having the
advantage of summarizing the effects of disparate
morbidities, can capture only those morbidities
affecting perceptions of health. For example, per-
sons with hypercholesterolemia or hypertension
may perceive little or no problems with their health.
It is thus possible that the relatively small racial
differences in the EQ-5D scores we observed are
attributable to differences in the causes of disease by
race. Hypertension, stroke, ischemic heart disease,
and trauma are major causes of morbidity and
mortality that are far more common in African-Americans than whites (Wong et al., 2002); how-
ever, until these conditions cause a major morbid or
mortal event they may have little impact on HRQL.
These conditions also tend to kill subjects faster
than others, sometimes via sudden death. Further,
the adverse consequences of hypertension may be
accelerated by the increased risk of undertreated
and undiagnosed disease suffered by African-
Americans compared with whites (Lopes et al.,
2003). Thus, adjusting for SES, African-Americans
may perceive less dysfunction than whites (as
captured by the EQ-5D) but be at increased risk
for premature, sudden mortality.
While the EQ-5D provides relatively clear cate-
gories for self-reported dysfunction (e.g., no pro-
blems in mobility, some problems, or severe
problems/unable to), differences in reporting can
nonetheless occur. For instance, one person with a
slight limp might report no problems while another
might report some problems. It is therefore possible
that African-Americans respond to EQ-5D ques-
tions differently than do whites, in a way that
underestimates their true disease burden. The
evidence for such differential item responding or
functioning (DIF) between African-Americans and
whites is mixed. DIF has been reported for the SF-
12 questionnaire in the same MEPS data we used to
estimate EQ-5D scores (Fleishman & Lawrence,
2003). The authors found evidence of DIF for
mental health functioning, with African-Americans
reporting apparently better mental health than
whites, but not for physical health functioning.
However, the size of the DIF effect in that study
was small and would not fully explain our findings.
We are not aware of any published evidence
indicating DIF by racial groups for the EQ-5D.
Our unpublished analyses of MEPS did not suggest
any substantive evidence of DIF with regard to the
EQ-5D (details available from the authors). Con-
versely, Bonham et al. reported an association
between John Henryism (the predisposition to
directly confront racism) and better self-reported
physical health in African-American men (Bonham,
Sellers, & Neighbors, 2004). While the role of John
Henryism in health is controversial, it is possible
that the average HRQL reported by African-
Americans is higher than might be reported in the
absence of racism. In turn, this would spuriously
diminish the apparent effects of morbidity on
African-Americans. Given the important role of
HRQL measures in policy analyses, and potential
implications for resource allocation of differential
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clarification of this issue is critical.
Given that HRQL has been found to be a strong
predictor of mortality (Idler & Benyamini, 1997), it
may seem counterintuitive that African-Americans
suffer greater mortality than whites but have a
similar HRQL. However, this disjunction parallels
the relationships observed for men and women.
Thus, men report better HRQL than women, but
have a shorter average life expectancy (Franks et al.,
2003). The gender disjunction between HRQL and
mortality may reflect differences in culturally
defined gender roles that make acknowledging
dysfunction more difficult for men. It also reflects
the greater prevalence of non-fatal diseases in
women. These gender effects suggest a possible
mechanism for the disjunction between HRQL and
mortality effects for African-Americans compared
with whites. However, our age-adjusted analyses
revealed no interaction between race and gender
effects, suggesting that gender does not mediate the
race disjunction between the HRQL and mortality.
While there was no significant difference in
HRQL after adjusting for SES, we did find
significant differences in mortality by race, differ-
ences that persisted after controlling for SES.
Differences in the burden of disease between
African-Americans and whites presumably reflect
socio-economic effects, the effects of racism on
health, and/or genetic differences. There has been
recent renewed interest in exploring the role of
genetic factors in understanding differences between
African-Americans and whites (Bamshad, 2005).
This is an area of great controversy partly because
racists have historically used false genetic arguments
to justify discriminatory policies, such as forced
sterilization, housing discrimination, and other
forms of mistreatment. There is also concern that
attributing disparities between African-Americans
and whites to genetic differences may undermine
efforts to reduce disparities (Pearce, Foliaki, Sporle,
& Cunningham, 2004; Sankar et al., 2004).
The recent release of a drug combination (nitrate/
hydralazine) to treat heart failure in African-
Americans has fueled this controversy (Taylor et
al., 2004). However, the finding that this drug
combination is more effective in African-Americans
than whites may point more to the spectrum of the
causes of heart failure than to genetic factors. Thus,
environmental factors (like racism, and increased
SES stress) may contribute to differences between
African-Americans and whites in the biologicalpathways causing heart failure (for example, small
vs. large vessel involvement), and thus differences in
the responses to drugs. Currently, there is little
evidence that genetic factors play a role in the
burden of disease of African-Americans. However,
research on these issues may yield a more complete
understanding about the causes and possible re-
medies for the health disparities.
In contrast, there is much more evidence that
racism and socio-economic factors account for the
health disparities (Williams, 1999). These factors
also interact with each other, compounding their
adverse effects on the health of African-Americans.
Kunitz and Pesis-Katz (2005) have shown how
slavery, residential segregation and persisting racism
contribute to the adverse health effects besetting
African-Americans. Perceived racism has also been
shown to have adverse health effects, with African-
Americans reporting racism exhibiting higher blood
pressure than those who do not (Krieger & Sidney,
1996). Also, perceived inequality may increase stress
hormone levels or stress reactivity, providing a
biological pathway for disease (Markowe et al.,
1985; McEwen, 1998; Williams, 1999). Skepticism,
anger, weaker social networks, less civic participa-
tion, and lower perceived social status are all
associated with a higher risk of morbidity and
premature mortality (Fiscella, Franks, Clancy,
Doescher, & Banthin, 1999; Kawachi & Berkman,
2001).
African-Americans have been found to have
lower levels of trust in their physicians and to be
more passive in encounters (Bird & Bogart, 2001;
Collins, Clark, Petersen, & Kressin, 2002; Doescher,
Saver, Franks, & Fiscella, 2000). Likewise, physi-
cians perceive and treat African-American patients
differently than their white counterparts (Bogart,
Catz, Kelly, & Benotsch, 2001; van Ryn & Burke,
2000). These impediments to optimal patient care
likely contribute to poorer outcomes for African-
American patients. These impediments are also
most likely based on unconscious racism in health
care, rather than larger structural problems. As
such, they may respond to downstream quality
improvement interventions (Fiscella, Franks, Gold,
& Clancy, 2000). Several such interventions show
promise of reducing disparities in health care
outcomes, including for immunizations (Szilagyi et
al., 2002; Zimmerman et al., 2003), and care for
renal failure (Sehgal, 2003), breast cancer (Shapiro,
Venet, Strax, Venet, & Roeser, 1982), hypertension
(Hypertension Detection and Follow-up Program
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Smith, 2002), and depression (Smith, Rost, Nutting,
Elliott, & Dickinson, 2002). Further downstream
interventions are needed that directly address
disparities.
The 50% reduction in disease burden observed
after SES adjustment is likely an underestimate of
the impact of SES on racial disparities. First,
income does not capture wealth, and wealth at
given income levels is lower in African-Americans
than whites (Kunitz & Pesis-Katz, 2005). Second,
our measure of education, years of schooling,
incompletely captures differences in school quality.
Other proximal and distal environmental effects,
also incompletely captured, include poorer and
more toxic neighborhoods, fewer job opportunities
(Lillie-Blanton, Parsons, Gayle, & Dievler, 1996;
Williams, 1999), and possibly poorer health care
(Bach, Pham, Schrag, Tate, & Hargraves, 2004).
Clearly, addressing the health effects of disparities
in SES will go a long way toward mitigating health
disparities between African-Americans and whites.
We have addressed elsewhere the burden of disease
associated with low income, which we estimated to
be over 17 million QALYs, much larger than the 2
million attributable to race disparities (Muennig,
Franks, Jia, Lubetkin, & Gold, 2005). Thus, while
addressing the effects of income disparities will
likely have a profound impact on race disparities,
the converse is unlikely to be true. Issacs and
Schroeder (Isaacs & Schroeder, 2004) have pointed
out how class is a relatively ignored aspect of
disparities in the US policy debate. In contrast to
the likely beneficial effects of downstream quality
improvement interventions on racial disparities
related to differences in health care, interventions
to address these SES disparities in health will also
need to address the upstream structural problems
underpinning these disparities. In England, the
Acheson report suggested enacting redistributive
policy reforms in order to improve health (Acheson,
1998). Some recommended policy changes have
been implemented, but outcome data are pending
(Marmot, 2004). While existing studies are promis-
ing (Katz, Kling, & Liebman, 2001; Kehrer &
Wolin, 1979; Schweinhart, 2004), further study is
needed to examine the effects of upstream policy
change on morbidity and mortality (Mechanic,
2005; Williams & Jackson, 2005).
There are a number of limitations to this analysis.
The foremost limitation is related to the use of
HRQL to assess total morbidity. While theapproach we used has the advantage of summariz-
ing morbidity effects and capturing aggregate effects
across disparate diseases, it is susceptible to a
number of problems.
First, HRQL scores may be vulnerable to
differences in beliefs and perceptions—factors that
may be influenced by cultural factors, income,
education level, and race/ethnicity (i.e., the DIF
noted above). However, some may view perceived
morbidity as more relevant than biologically mea-
sured morbidity.
Second, because of differences in the methods by
which health states are valued, different generic
preference-weighted instruments may produce dif-
ferent HRQL scores, and thus different estimates of
the burden of disease (Gold & Muennig, 2002).
Even for the same instrument, different weighting
systems can produce dramatically different scores.
For instance, the use of US weights compared with
UK weights produces EQ-5D Index scores that are
systematically higher; thus, the effects of any given
morbidity on HRQL using US weights is less than
that using UK weights (Johnson, Luo, Shaw, Kind,
& Coons, 2005).
Third, while the EQ-5D displays reasonable
reliability and validity when compared to other
HRQL measures, the measure has known ceiling
effects stemming from the limited number of
severity levels assessed (Coons, Rao, Keininger, &
Hays, 2000; Gold et al., 1996). In turn, this ceiling
effect may result in underestimation of the full
effects of morbidity on HRQL relative to other
HRQL measures, especially for mildly impaired
health states.
Other limitations relate to our mortality analyses.
Inconsistencies have been noted in reporting race
and ethnicity on death certificates, but these effects
are small (Minino et al., 2002). Also, we calculated
the effect of mortality on SES using data from 1990
through 1995 because more recent data were not
available to us. However, the relative risk among
African-Americans relative to whites has changed
little since 1960, suggesting that temporal changes
by SES might be small if they exist at all (Minino et
al., 2002). Our mortality data are also consistent
with those of Satcher et al., who used a different
methodology and 2002 data (Satcher et al., 2005).
When tested against life tables produced by the
NCHS, our models showed little evidence of bias in
mortality; the product of age-specific HRs for
African-Americans (unadjusted for SES) and
2000 white mortality probabilities produced a life
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produced by actual life tables for African-
Americans in 2000. This also serves as evidence
suggesting that the HRs have not changed much
since 1995.
In summary, this study suggests that the burden
of disease suffered by African-Americans in the US
is largely embedded in the broader problem of the
adverse effects of SES disparities. Beyond these
SES effects, racial disparities are most likely related
to the effects of racism. While downstream
quality improvement interventions may have
success in reducing disparities in health care,
addressing the adverse effects of SES disparities in
health will likely involve upstream structural
changes. Research geared toward identifying novel
upstream and downstream approaches to reducing
both SES and racial disparities in health is greatly
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